undamentalytics Newsletter
Sign in

ICL Group Ltd. (ICL) stock

Add to watchlist

Add holding +

NYSE: ICL NYSE Fertilizers & Agricultural Chemicals Next results ~November 11, 2026

C+ Fundamentals grade

ICL Group Ltd. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$8.6

Cash-flow model

Base case. Range ~$5.9–$12 across our lower- and higher-growth cases (-1%–9% a year).

Price vs value

Undervalued

The price is below our entire value range; our base value is 97% above it.

Price used: $4.38, November 3, 2026

ICL Group Ltd. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds134 adding, 94 cuttingOf 24 active managers that changed their stake, 11 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter ICL Group files

Where ICL stands after its latest Filing

Revenue for the twelve months was $7.15bn, up 4.6% on a year earlier, against a decline of 9.2% a quarter earlier. Free-cash-flow margin fell to 4.6% from 8.4% a year earlier. Operating margin narrowed to 8.1% from 17.4%. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 4 of our 7 financial-health checks. Our cash-flow model value is $8.64 a share, against a share price of $4.58. At that price, our model says the market is pricing in cash flow shrinking about 4.2% a year for five years, slower than the 7.2% a year revenue growth it has delivered.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 11, 2026 (estimated)

ICL Group Ltd.'s trailing-twelve-month revenue grew 4.6% year on year, with a free-cash-flow margin of 4.6%. Where it stands out: change in growth rate of +13.8pp ranks 2 of 11 fertilizers & agricultural chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$8.6 per share in the base case (~$5.9–$12 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 61.5% while net income fell 44.5%: a 17pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $4.57 is 89% below our value per share of $9.
  • Growth speeding up. The growth rate is 13.8 points higher than a quarter earlier.

Things to watch

  • Margins narrowing. Operating margin is down 3.2 points on a year ago.
  • Gross margin slipping. Gross margin is down 2.4 points on a year ago.

Latest results

Earnings per share
$0.12 against an average estimate of $0.11: beat by 12.7%
Next report
November 11, 2026; average EPS estimate $0.10

ICL Group's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-4.2%
  • 1 week-11.0%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$7.2B
Operating margin
8.1%
Net margin
3.2%
EPS (TTM, diluted)
$0.17

Growth

Revenue growth
+4.6%
Change in growth rate
+13.8 pts
Share count change
+0.1%

Cash

Free cash flow (TTM)
$330M
FCF margin
4.6%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for ICL from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

ICL Group Ltd. valuation models and calculator

What the price is pricing in

The share price implies cash flow shrinking about 4.7% a year for five years.That is slower than the 7.2% a year revenue growth ICL Group has delivered.

  • Priced in-4.7%
  • Last 12 months4.6%
  • 3 years a year-10.6%
  • 5 years a year7.2%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($4.38, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$8.6
Price used
$4.38close November 3, 2026
Implied change
▲ +97%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of ICL Group Ltd.'s free cash flow after stock-based pay with after-tax interest added back ($745M, FY2025 Q4 TTM), growing 4% a year for five years and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$5.9–~$12 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of ICL Group Ltd.'s free cash flow after stock-based pay ( $745M, FY2025 Q4 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value ICL Group Ltd. as an operating company, with every model that fits that kind of business. Cost of equity 7.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.65 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$8.6 ~$5.9–$12 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$4.5 ~$4.6–$6.0 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$11 ~$7.9–$15 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$13 ~$11–$17 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$9.1 ~$4.5–$13 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare ICL Group Ltd. with Fertilizers & Agricultural Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −38%
  • Revenue growth 5 points higher ▲ +49%
  • Free-cash-flow margin 1 point lower ▼ −25%
  • Last year's free-cash-flow margin change, if it persists ▼ −67%
  • Discount rate 1 point higher ▼ −22%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $6$9$13$18$25$34
8.5% $4$6$9$13$18$24
10% $3$5$7$10$13$18

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 11, 2026, before the open. Analysts expect EPS of $0.10 (range $0.08 to $0.11) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.41 +13% $8.0bn +12%
Next $0.43 +7% $8.2bn +3%

Next year's EPS estimate has moved −3.4% in 90 days, across 4 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −2.8% on 90 days ago. In the last 30 days, 2 analysts raised ICL Group Ltd.'s forecast and 1 cut it.

Consensus EPS forecast ICL Group Ltd., last 90 days
$0.40 $0.42 $0.44 $0.46 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $0.42 Current fiscal year, 60 days ago: $0.43 Current fiscal year, 30 days ago: $0.42 Current fiscal year, 7 days ago: $0.42 Current fiscal year, Now: $0.41 $0.41 Next fiscal year, 90 days ago: $0.45 Next fiscal year, 60 days ago: $0.44 Next fiscal year, 30 days ago: $0.44 Next fiscal year, 7 days ago: $0.44 Next fiscal year, Now: $0.43 $0.43

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $0.42$0.45
60 days ago $0.43$0.44
30 days ago $0.42$0.44
7 days ago $0.42$0.44
Now $0.41$0.43

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.11 $0.12 +12.7%
Dec 2025 $0.09 $0.09 −3.2%
Sept 2025 $0.10 $0.10 +5.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

4 analysts, Nov 2026
Buy00%
Hold4100%
Sell00%

Monthly trend

  1. Nov 202644
  2. Oct 202644
  3. Sep 202644

Counts of recommendations published by analysts covering ICL Group Ltd., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.5%
of tradable shares
Days to cover
3.14
at average volume
Short interest, 1 month
+2%
to October 15, 2026
Held by institutions
44%
of shares
Held by insiders
43.9%
of shares
Employees
12,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Options strategies

All options ideas

How ICL Group Ltd.’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 3, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade C+ (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

ICL Group Ltd. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) ICL Group Ltd.
$4B $6B $8B $10B $12B FY15 Q4 FY17 Q4 FY19 Q4 FY21 Q4 FY23 Q4 FY25 Q4 Revenue (TTM), FY15 Q4: $5.4B Revenue (TTM), FY16 Q4: $5.4B Revenue (TTM), FY17 Q4: $5.4B Revenue (TTM), FY18 Q4: $5.6B Revenue (TTM), FY19 Q4: $5.3B Revenue (TTM), FY20 Q4: $5B Revenue (TTM), FY21 Q4: $7B Revenue (TTM), FY22 Q4: $10B Revenue (TTM), FY23 Q4: $7.5B Revenue (TTM), FY24 Q4: $6.8B Revenue (TTM), FY25 Q4: $7.2B $7.2B

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Revenue (TTM)
FY15 Q4 $5.4B
FY16 Q4 $5.4B
FY17 Q4 $5.4B
FY18 Q4 $5.6B
FY19 Q4 $5.3B
FY20 Q4 $5B
FY21 Q4 $7B
FY22 Q4 $10B
FY23 Q4 $7.5B
FY24 Q4 $6.8B
FY25 Q4 $7.2B
Revenue growth, TTM YoY ICL Group Ltd.
-40% -20% 0% 20% 40% 60% FY16 Q4 FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 Revenue growth, TTM YoY, FY16 Q4: -0.8% Revenue growth, TTM YoY, FY17 Q4: 1.0% Revenue growth, TTM YoY, FY18 Q4: 2.5% Revenue growth, TTM YoY, FY19 Q4: -5.1% Revenue growth, TTM YoY, FY20 Q4: -4.3% Revenue growth, TTM YoY, FY21 Q4: 37.9% Revenue growth, TTM YoY, FY22 Q4: 44.0% Revenue growth, TTM YoY, FY23 Q4: -24.8% Revenue growth, TTM YoY, FY24 Q4: -9.2% Revenue growth, TTM YoY, FY25 Q4: 4.6% 4.6%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Revenue growth, TTM YoY
FY16 Q4 -0.8%
FY17 Q4 1.0%
FY18 Q4 2.5%
FY19 Q4 -5.1%
FY20 Q4 -4.3%
FY21 Q4 37.9%
FY22 Q4 44.0%
FY23 Q4 -24.8%
FY24 Q4 -9.2%
FY25 Q4 4.6%
Operating margin (TTM) ICL Group Ltd.
-10% 0% 10% 20% 30% 40% FY15 Q4 FY17 Q4 FY19 Q4 FY21 Q4 FY23 Q4 FY25 Q4 Operating margin (TTM), FY15 Q4: 14.2% Operating margin (TTM), FY16 Q4: -0.1% Operating margin (TTM), FY17 Q4: 11.6% Operating margin (TTM), FY18 Q4: 27.3% Operating margin (TTM), FY19 Q4: 14.3% Operating margin (TTM), FY20 Q4: 4.0% Operating margin (TTM), FY21 Q4: 17.4% Operating margin (TTM), FY22 Q4: 35.1% Operating margin (TTM), FY23 Q4: 15.1% Operating margin (TTM), FY24 Q4: 11.3% Operating margin (TTM), FY25 Q4: 8.1% 8.1%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Operating margin (TTM)
FY15 Q4 14.2%
FY16 Q4 -0.1%
FY17 Q4 11.6%
FY18 Q4 27.3%
FY19 Q4 14.3%
FY20 Q4 4.0%
FY21 Q4 17.4%
FY22 Q4 35.1%
FY23 Q4 15.1%
FY24 Q4 11.3%
FY25 Q4 8.1%
FCF margin (TTM) ICL Group Ltd.
0% 5% 10% 15% 20% FY15 Q4 FY17 Q4 FY19 Q4 FY21 Q4 FY23 Q4 FY25 Q4 FCF margin (TTM), FY15 Q4: 2.6% FCF margin (TTM), FY16 Q4: 10.4% FCF margin (TTM), FY17 Q4: 7.9% FCF margin (TTM), FY18 Q4: 3.6% FCF margin (TTM), FY19 Q4: 10.6% FCF margin (TTM), FY20 Q4: 4.5% FCF margin (TTM), FY21 Q4: 8.4% FCF margin (TTM), FY22 Q4: 16.3% FCF margin (TTM), FY23 Q4: 15.6% FCF margin (TTM), FY24 Q4: 12.5% FCF margin (TTM), FY25 Q4: 4.6% 4.6%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period FCF margin (TTM)
FY15 Q4 2.6%
FY16 Q4 10.4%
FY17 Q4 7.9%
FY18 Q4 3.6%
FY19 Q4 10.6%
FY20 Q4 4.5%
FY21 Q4 8.4%
FY22 Q4 16.3%
FY23 Q4 15.6%
FY24 Q4 12.5%
FY25 Q4 4.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar ICL Group took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $7.2B
  2. Cost of revenue $5B · 69.4%
  3. Gross profit $2.2B · 30.6%
  4. Research and development $70M · 1.0%
  5. Other operating costs $1.5B · 21.5%
  6. Operating income $580M · 8.1%
  7. Income tax $161M · 2.3%
  8. Interest and other $193M · 2.7%
  9. Net income $226M · 3.2%

Shares of revenue. Source: ICL Group's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 5.4 5.4 5.4 5.6 5.3 5.0 7.0 10.0 7.5 6.8 7.2
Gross profit 1.8 1.7 1.7 1.9 1.8 1.5 2.6 5.0 2.7 2.3 2.2
EBITDA 1.2 0.4 1.0 1.9 1.2 0.8 1.7 4.0 1.7 1.4 1.3
Operating income 0.8 −0.0 0.6 1.5 0.8 0.2 1.2 3.5 1.1 0.8 0.6
Net income 0.5 −0.1 0.4 1.2 0.5 0.0 0.8 2.2 0.6 0.4 0.2
Diluted EPS $0.40 −$0.10 $0.29 $0.97 $0.37 $0.01 $0.60 $1.67 $0.50 $0.32 $0.18
Growth (year on year)
Revenue — −0.8% +1.0% +2.5% −5.1% −4.3% +37.9% +44.0% −24.8% −9.2% +4.6%
EBITDA — −66.3% +159.8% +85.2% −38.7% −34.3% +116.9% +137.0% −58.2% −17.4% −5.7%
Operating income — −100.4% — +141.5% −50.2% −73.3% +499.0% +190.6% −67.5% −32.1% −25.2%
Net income — −124.0% — +240.7% −61.7% −97.7% — +175.7% −70.0% −37.1% −44.5%
Diluted EPS — −125.0% — +234.5% −61.9% −97.3% — +178.3% −70.1% −36.0% −43.8%
Margins
Gross margin 33.4% 31.0% 30.9% 33.4% 34.5% 29.5% 37.5% 50.2% 35.4% 33.0% 30.6%
EBITDA margin 22.1% 7.5% 19.3% 34.9% 22.6% 15.5% 24.4% 40.1% 22.3% 20.2% 18.3%
Operating margin 14.2% −0.1% 11.6% 27.3% 14.3% 4.0% 17.4% 35.1% 15.1% 11.3% 8.1%
Net margin 9.4% −2.3% 6.7% 22.3% 9.0% 0.2% 11.3% 21.6% 8.6% 5.9% 3.2%
Cash flow
Cash from operations 0.6 1.0 0.8 0.6 1.0 0.8 1.1 2.1 1.7 1.5 1.1
Stock-based pay 0.0 0.0 0.0 0.0 0.0 — — — — — —
Balance sheet
Cash 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.4 0.4 0.3 0.3
Total debt 0.0 3.4 3.2 2.4 2.6 2.7 3.0 2.8 2.7 2.3 2.8
Net debt (negative = net cash) −0.2 3.3 3.1 2.3 2.5 2.5 2.5 2.4 2.3 2.0 2.5
Diluted shares 1,272m 1,273m 1,277m 1,280m 1,282m 1,280m 1,287m 1,290m 1,291m 1,290m 1,291m
Returned to shareholders
Dividends 0.3 0.2 0.2 0.2 0.3 0.1 0.3 1.2 0.5 0.3 0.2
Total returned 0.3 0.2 0.2 0.2 0.3 0.1 0.3 1.2 0.5 0.3 0.2

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 7 checks passed · December 31, 2025
What it owns · $12.4bn
Short-term assets $4.2bnLonger-term assets $8.2bn
What it owes, and who funded it · $12.2bn
Short-term liabilities $3.1bnLonger-term liabilities $3.0bnShareholders' equity $6.0bn
  • Short-term assets cover short-term liabilities $4.2bn of assets due within a year against $3.1bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $4.2bn short-term assets against $3.0bn of longer-dated liabilities.
  • More cash than debt $291m of cash against $2.8bn of debt.
  • Debt below 40% of shareholders' equity Debt is 46% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 52% to 46% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.1bn of operating cash flow against $2.8bn of debt.
  • Operating profit covers interest at least five times over Operating income of $580m against $117m of interest.

From ICL Group Ltd.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$224M
Returned to shareholders
68%
of free cash flow
Diluted share count
+0.1%
year over year
Total shareholder yield
3.8%
dividends 3.8% + buybacks 0.0% of market value
Dividend payout ratio
99%
of net income paid out
R&D spending
1.0%
of revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated ICL CF MOS SMG CTVA FMC Median
Revenue, last 12 months $7.2bn $7.7bn $12.2bn $3.5bn $17.8bn $2.8bn $3.5bn
Revenue growth, last 12 months 4.6% 20.0% 8.8% 4.6% 3.7% −22.0% 3.7%
Revenue growth, 3-year average — −3.9% −10.0% −1.7% 0.5% −17.2% −4.2%
Revenue growth, latest quarter — 17.6% −6.0% 1.1% −1.2% −80.5% −1.2%
Gross margin 30.6% 42.5% 11.0% 31.8% 49.5% 22.0% 31.0%
Operating margin 8.1% 41.1% −1.4% 11.0% — −97.0% 3.4%
Operating margin, 3-year average 12.4% 32.7% 4.2% 6.8% — −29.8% 6.8%
Net margin 3.2% 27.1% −5.2% 2.1% 5.7% −151.2% 2.1%
Cash from operations / revenue 14.8% 38.5% 3.6% 10.6% 6.8% 15.1% 14.8%
Free-cash-flow margin 4.6% 24.7% −7.7% 7.6% 3.5% 13.1% 7.4%
Free-cash-flow margin, 3-year average 7.0% 26.0% −1.3% 14.4% 9.2% 5.8% 9.1%
Stock pay / revenue 0.2% 0.6% 0.3% 1.4% 0.5% 0.9% 0.6%
Change in share count 0.1% −8.6% −0.1% 3.2% −1.9% 1.5% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 4.6% 3.7% 5 of 11
Change in growth rate Growth +13.8pp -0.8pp 2 of 11
Gross margin Profitability 30.6% 31.0% 7 of 11
Operating margin Profitability 8.1% 8.1% 5 of 9
Net margin Profitability 3.2% 2.1% 5 of 11
Free-cash-flow margin Cash generation 4.6% 7.4% 7 of 11
Long-term debt as % of assets Balance sheet 15.1% 21.3% 3 of 11
Change in share count Balance sheet 0.1% 0.1% 6 of 11

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$983M
Institutions reporting
218
Shares held vs prior quarter
▼ 3.5%
Positions opened / closed
35 / 37

Top buyers and sellers, Q2 2026: 134 institutions bought and 94 sold ; the biggest buyer was Goldman Sachs Group Inc (+2.5M shares) and the biggest seller Meitav Investment House Ltd (−29.8M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Altshuler Shaham Ltd $120M 24.0M 12.2% ▲ 7.6%
Norges Bank $107M 21.3M 10.9% —
Vanguard Capital Management LLC $105M 20.9M 10.7% ▲ 1.2%
Clal Insurance Enterprises Holdings Ltd $99.4M 19.8M 10.1% ▼ 10.1%
Y.D. More Investments Ltd $97.8M 19.5M 9.9% ▼ 0.6%
Phoenix Financial Ltd. $77.6M 15.6M 7.9% ▲ 1.7%
Morgan Stanley $49M 9.8M 5.0% ▲ 31.7%
Vanguard Fiduciary Trust Co $32.4M 6.5M 3.3% ▲ 1.1%
Blackrock, Inc. $28.6M 5.7M 2.9% ▲ 26.8%
Goldman Sachs Group Inc $27.3M 5.5M 2.8% ▲ 81.7%
Legal & General Group PLC $22.5M 4.5M 2.3% ▲ 3.3%
Swiss National Bank $12.8M 2.5M 1.3% ▼ 10.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not ICL Group Ltd.'s complete shareholder register. Values are as reported by the filers ; 7 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 3 trades and filings

No trades in ICL Group Ltd. disclosed in the last 12 months; 3 earlier trades on record.

  • Daniel S. Goldman(D-NY 10):Sale (full), $1,001 - $15,000, traded July 10, 2023, filed August 13, 2023
  • Greg Gianforte(MT):Sale (partial), $15,001 - $50,000, traded November 13, 2020, filed December 2, 2020
  • Greg Gianforte(MT):Purchase, $15,001 - $50,000, traded December 14, 2017, filed January 4, 2018

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on ICL Group Ltd. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

ICL Group Ltd. in brief

What does ICL Group Ltd. do?
ICL Group Ltd. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.
What is ICL Group Ltd.'s stock ticker?
ICL Group Ltd. trades under the ticker ICL on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is ICL Group Ltd.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, ICL Group Ltd. reported revenue of $7.2B, 4.6% higher than a year earlier, according to its SEC filings.
What is ICL Group Ltd.'s free cash flow?
ICL Group Ltd.'s free-cash-flow margin is 4.6% of revenue over the trailing twelve months, ranking 7 of the 11 fertilizers & agricultural chemicals companies we cover.
What is ICL Group Ltd.'s fair value (intrinsic value) per share?
Our discounted-cash-flow model of ICL Group Ltd.'s free cash flow after stock-based pay gives ~$8.6 per share in the base case, and ~$5.9–$12 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are ICL Group Ltd.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Altshuler Shaham Ltd, Norges Bank and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Does ICL Group Ltd. pay a dividend?
Yes: ICL Group Ltd. paid $224M in dividends over the trailing twelve months, a dividend yield of 3.80% and a payout ratio of 99.1%.
How much debt does ICL Group Ltd. have?
ICL Group Ltd.'s debt-to-equity ratio is 46.1%, from its latest balance sheet (52.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are ICL Group Ltd.'s competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to ICL Group Ltd. are CF Industries, The Mosaic Company, Scotts Miracle-gro Co, Corteva, Inc. and FMC Corp. The side-by-side comparison below sets their revenue, margins and growth against ICL Group Ltd.'s.
When is ICL Group Ltd.'s next earnings date?
Around November 11, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — ICL Group Ltd. announces its own schedule.